Possible scenario
Broader Research Restrictions
25% Chance
The article strengthens the case for a broader crackdown on high-risk pathogen work, building on prior Trump administration scrutiny of risky virus research. New rules would not end Ebola work but would slow grants, animal challenge studies, and some government-funded biosafety contracts.
Secondary impacts
- Healthcare -1.0%
- Business Services -0.7%
- Industrials -0.1%
Tickers
- CRL-2.2%
- LH-0.7%
- MRK-0.6%
- -0.2%
Portfolio impact
S&P 500-0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.